Deals channel feed – Endpoints News

Deals channel feed

Pfizer says it has at least $10B available for deals in 2025, with a focus on pipeline

3 months ago

Biogen’s revised research strategy is to avoid becoming obsolete, top exec says

3 months ago

Roche aims for derisked deals and ruthless portfolio cuts in 2025

3 months ago

Sanofi is in the market for M&A, thanks to ‘strong’ balance sheet

3 months ago

Lonza looks to buy facilities and tech to boost service offerings

3 months ago

Lantheus to buy radiopharma CDMO and diagnostic assets for $250M upfront

3 months ago

Sage turns down Biogen's buyout offer and will look at other options

3 months ago

Exclusive: Leerink builds healthcare M&A team, poaching dealmakers from rivals

3 months ago

Agenus continues partnership talks for anti-CTLA-4 combo with new Phase 2 data

3 months ago

AbbVie partners with Neomorph in latest molecular glue deal

3 months ago

BioMarin turns to ex-Roche dealmaker James Sabry to build ‘next version’ of 27-year-old company

3 months ago

Oncology biotech ArriVent does another China ADC deal, this time with Lepu Biopharma

3 months ago

Another US biotech emerges with drug candidate from China-based Keymed

3 months ago

A mixed year for deals and dollars left biotech execs hungry for a better 2025

3 months ago

Regenxbio sells Hunter syndrome license with FDA filing underway

3 months ago

Australia's BioCina and NovaCina join forces to make one CDMO

3 months ago

Daiichi Sankyo brings Glycotope antibody in-house for $132.5M

3 months ago

Lilly to acquire cancer biotech Scorpion, which shares a co-founder with Loxo

3 months ago

AstraZeneca, CRISPR tools supplier ink gene editing enzyme licensing deal

3 months ago

Updated: J&J to buy Intra-Cellular for $14.6B in latest neuroscience bet

3 months ago

#JPM25 live blog day 1: How will Trump 2.0 impact the biopharma industry? Scott Gottlieb, Bob Nelsen share perspectives

3 months ago

Gilead taps into STAT6 space via $250M deal with Leo Pharma

3 months ago

GSK kicks off JPM dealmaking with $1B+ buyout of IDRx and its rare cancer drug

3 months ago

Lantheus to buy Life Molecular Imaging for $350M, netting Alzheimer's diagnostic

3 months ago

First page Previous page 2 3 456 7 8 Next page Last page